The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland. QBI and UCD recently signed a five-year memorandum of understanding (MOU) to reinforce the links between scientists in San Francisco and Dublin, and enhance their collaborative ability to strengthen scientific research and innovation.
QBI presents a Twitter Space (live audio conversation) with Jennifer Doudna, Nobel Laureate, co-inventor of CRISPR-Cas9, professor of cellular molecular pharmacology at UCSF, and biochemist at the University of California, Berkeley. Doudna received her PhD in biological chemistry and molecular pharmacology from Harvard Medical School in 1989. She completed her postdoctoral studies at the University of Colorado and then joined the Yale faculty in 1994.
Thursday, September 22, 2022 - 11:00 am to 12:00 pm
The QBI seminar series is presenting John Walter, a visual artist based in London with a longstanding interest in HIV, infectious diseases, and a commitment to expanding the public understanding of virology through projects such as Alien Sex Club (2015) and CAPSID (2018). He works across a diverse range of media that includes drawing, painting, video, VR, installation, and performance.
I am a member of the Center for Translational and Policy Research on Precision Medicine (TRANSPERS). I am interested in the ways that insurance coverage and health policy shape differential access and uptake of precision medicine. I am particularly interested in applying my research towards efforts aimed at diversifying the population of people who can realize the benefits of these new health technologies.
I manage the Chemistry and Chemical Biology Graduate Program. As graduate program coordinator, I manage all aspects of the program including admissions and recruitment, funding, grants, events, and curriculum.
